Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of the Resection Margins and the Ganglionic Status Using a Quality Standard Resection for Adenocarcinoma of the Head of the Pancreas.

NCT00918853 is registered in ClinicalTrials.gov with Institut Paoli-Calmettes as lead sponsor.

NCT NCT00918853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00918853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of the Resection Margins and the Ganglionic Status Using a Quality Standard Resection for Adenocarcinoma of the Head of the Pancreas.
Lead sponsor
Institut Paoli-Calmettes
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2008
Completion date
May 31, 2012
Enrollment
156 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, pancreas